US Patent 7803790 Compounds for modulating TRPV3 function

Patent 7803790 was granted and assigned to Hydra Biosciences on September, 2010 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

September 28, 2010

Patent Application Number

11431942

Date Filed

May 9, 2006

Patent Primary Examiner

Patent abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7803790 Compounds for modulating TRPV3 function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.